American healthcare spends over $5 trillion annually—more than any other nation—yet invests comparatively little in prevention. A new study published in Nature Medicine provides compelling evidence that one simple intervention can dramatically bend the cost curve: meals specifically designed for patients with serious, diet-sensitive illnesses.
Researchers from Tufts University's Food is Medicine Institute and the University of Massachusetts Chan Medical School, working with several of Massachusetts' largest healthcare systems, tracked outcomes for Medicaid members who received six months of medically tailored meals. The results were striking: a 31 percent reduction in hospitalizations and a 20 percent drop in emergency room visits. The meals, created by registered dietitians at the Boston-based nonprofit Community Servings, were prescribed for patients managing conditions like kidney disease, cardiovascular disease, diabetes, and depression.
The financial impact was equally impressive. The program generated average healthcare savings of $3,433 per person, essentially covering its own cost. Savings were even higher for specific conditions: $12,312 for kidney disease, $10,450 for cardiovascular disease, $5,597 for depression and anxiety, and $4,123 for diabetes. These peer-reviewed findings align with a growing body of research showing that food-as-medicine programs can both improve health and reduce spending.
“When you prescribe the nourishing meals that people require, they get healthier—and the system spends less,” said Dariush Mozaffarian, a cardiologist and director of the Food is Medicine Institute at Tufts. David Waters, CEO of Community Servings and founder of the AMPL Institute, added that the evidence should be a wake-up call for policymakers.
Policy Push in Congress
The study arrives as lawmakers consider the Medically Tailored Home-Delivered Meals Demonstration Pilot Act, a bipartisan bill that would create a six-year Medicare pilot in 10 states. Supporters say the pilot would lay the groundwork for broader coverage of medically tailored meals for seniors with chronic diet-related conditions. The bill has backing in both chambers of Congress.
But advocates warn that without evidence-based standards, insurers could end up paying for meals labeled “medically tailored” that lack the clinical rigor needed to deliver real results. The national Food is Medicine Coalition, a network of 15 accredited nonprofit providers including Community Servings, has already developed a standard for such interventions.
“Without a defined standard, insurance programs risk paying for meals merely labeled as ‘medically tailored’ but lacking the rigor to improve health and lower costs,” Waters said.
Gaps in Coverage and Research
Despite the promise, access remains severely limited. In Massachusetts alone, 220,000 people qualify for medically tailored meals across Medicaid, Medicare, and commercial insurance. Yet Community Servings will serve fewer than 4 percent of them—about 8,000 individuals—this year, due to inconsistent insurance coverage, lack of medical training for doctors, and fragmented referral pathways.
Mozaffarian and Waters argue that funding for nutrition research has been neglected by top national agencies like the National Institutes of Health. They are urging Congress to prioritize nutrition science and to move swiftly to integrate medically tailored meals into Medicare and Medicaid as a standard therapy.
“We know it works. It’s time to deliver it at scale,” they wrote. “Without decisive action, without swift policy change at federal and state levels, too many people who need medically tailored meals still cannot get it.”
The study's findings come amid broader debates over healthcare costs and access. As Democrats push for a new healthcare agenda ahead of the midterms, and as critics highlight vast inequalities in the current system, the case for food-as-medicine has never been stronger.
For now, the authors are clear: “We can do more. We can do better. And we know how: Let us make medically tailored meals a standard available therapy in Medicare and Medicaid.”
